Advertisement
photo: IRA_EVVA/Shutterstock.com
photo: IRA_EVVA/Shutterstock.com

During the last years, cannabidiol has gained increasing interest in the world of cosmetics. Not all skin benefit claims, however, are based on efficacy studies and consumers wonder whether it really has a positive influence on the skin. Dr Katharina Kappler reports on the latest results on the effects of CBD in cosmetics.

As a trend ingredient in many skin care products worldwide, CBD promises skin soothing and relaxation, as well as a reduction of skin redness and inflammation. Not all skin benefit claims, however, are based on efficacy studies and consumers wonder whether it really has a positive influence on the skin.

Indeed, CBD provides numerous health benefits. In 2018, the FDA approved the first prescription drug based on CBD for the treatment of epileptic seizures1. Moreover, ingestion or inhalation is used to treat anxiety, depression, chronic pain, and insomnia2. The biochemical function is well understood for these systemic applications, but the effects for topical CBD applications are still less clear.

figure 1: Inhibition of inflammation induced PGE2 release by treatment with CBD+pinosylvin. figures: Mibelle Biochemistry
figure 1: Inhibition of inflammation induced PGE2 release by treatment with CBD+pinosylvin. figures: Mibelle Biochemistry

Proven effects on the skin

Several studies have proven the successful absorption of topically applied CBD into the skin3. Due to the hydrophobic nature, appropriate carrier systems, however, are necessary to allow efficient uptake into the skin. Within the skin, the existence of the endocannabinoid system provides a plausible explanation of how CBD could lead to the claimed effects.

The endocannabinoid system is a signalling network that has been mainly described to modulate the central nervous system and immune functions, but it also exists in the skin, where nine endocannabinoids are present4. The main targets for cannabinoids in the nervous system – cannabinoid receptor 1 and 2 – as well as additional targets for cannabinoids, such as transient receptor potential (TRP) and peroxisome proliferator activated (PPA) receptors, are expressed in different skin cells, including fibroblasts and keratinocytes3. Even though the signalling pathways of the endocannabinoid system could explain some of the CBD effects in the skin, there are only a few publications, which prove these functions. 

figure 2: Increased speed of tissue regeneration after treatment with CBD or CBD+ pinosylvin. figures: Mibelle Biochemistry,
figure 2: Increased speed of tissue regeneration after treatment with CBD or CBD+ pinosylvin. figures: Mibelle Biochemistry,

Based on literature research, we have identified four major effects of CBD in the skin:

  • Antioxidant function: CBD increases the expression of antioxidant genes, such as HMOX1, by stimulating the transcription factor NRF2 in human keratinocytes5,6. Furthermore, it prevents lipid peroxidation and protects from hydrogen peroxide-induced oxidative stress and cell death6,7.
  • Anti-inflammatory properties: CBD can inhibit the pro-inflammatory transcription factor NF-kB and thereby modulate inflammation in UVA-irradiated keratinocytes6. It has been suggested that CBD inhibits NF-kB mainly via the activation of receptor PPARγ8.
  • Soothing effect: CBD can desensitise TRPV1 (TRP Vanilloid-1), a pain receptor that is expressed in nerve fibres but also in kera-tinocytes and can thereby potentially lead to pain relief and skin soothing9.
  • Wound healing improvement: Topical application of CBD was shown to increase the expression of cytokeratin genes KRT16 and KRT17, which are associated with keratinocyte proliferation and wound repair5.

Due to these positive effects on the skin and the ability to regulate lipid production10,11, CBD has been discussed for the treatment of acne, seborrhoea, eczema, and atopic dermatitis3, even though additional studies are needed to confirm its efficacy.

figure 3: Reduction of skin roughness and wrinkles after treatment with CBD+pinosylvin. figures: Mibelle Biochemistry
figure 3: Reduction of skin roughness and wrinkles after treatment with CBD+pinosylvin. figures: Mibelle Biochemistry

Synergistic effects with Swiss stone pine extract

For our own studies, we used purified CBD, which was encapsulated into a nano emulsion using organic hemp seed oil. This step not only improves the water solubility of CBD, but also increases the bioavailability in the skin. The encapsulated CBD was then combined with a Swiss stone pine (Pinus cembra) extract for a synergistic effect.

The Swiss stone pine, a tree that grows in high altitudes, is notably rich in the molecule pinosylvin, a stilbenoid like resveratrol, which is known to reduce inflammation and neutralise free radicals. This combination, called CBD+pinosylvin12 in the following, was tested in several studies to investigate the effect on skin inflammation, wound healing, and facial relaxation.

The anti-inflammatory activity of CBD+pinosylvin was measured in human keratinocytes by the release of prostaglandin E2 (PGE2), a potent proinflammatory mediator. Cells were treated either with the combination of ingredients before induction of inflammation by phorbol myristate acetate and measurement of PGE2 in the supernatant of the cells. The treatment with the ingredient’s combination inhibited PGE2 release dose-dependently with a maximal inhibition of 84% at the highest concentration of 0.1% (figure 1). This inhibitory effect was comparable to that of indomethacin, an established inhibitor of PGE2 release. Thus, the treatment with CBD+pinosylvin can reduce inflammation in the skin, which could also lead to a reduction in skin redness, as PGE2 release leads to vasodilation.

To test the wound healing capacity of CBD+pinosylvin, a scratch assay was performed in human keratinocytes treated with either 0.004% of the combination of the ingredients or an equivalent concentration of CBD in DMSO. While both treatments had a positive effect on cell proliferation, the combination accelerated wound healing more strongly than CBD alone (figure 2). A possible explanation for this observation is the synergistic activity of CBD and the Swiss stone pine extract as well as the increased bioavailability of the encapsulated CBD.

In a placebo-controlled clinical study with 41 volunteers (38-65 years), the skin roughness on the subjects’ cheeks and the number of wrinkles in the crow’s feet area were measured to investigate the effect of smoothing the skin texture due to facial relaxation. The volunteers were split into two groups and used either a cream with 2% CBD+pinosylvin or a corresponding placebo cream on the face twice daily for 28 days. The treatment with the combination of ingredients led to a significant reduction of the number of wrinkles by 28% and skin roughness by 6.5% (figure 3). In addition, the relaxing effect was analysed using an image-based method, which visualises all changes on the skin surface that occur during the treatment. The most remarkable differences were along the jawline, where an upward movement was observed, and on the cheeks, where the volume of the skin surface was slightly increased. 

In the same study, skin colour was analysed using a technology that detects vascular structures and hyper-pigmented spots and quantifies the red and brown colour intensities. Compared to initial conditions, treatment with 2% CBD+pinosylvin led to a significant reduction of the clusters of melanin and haemoglobin by 13.7% and 17.8% after 28 days, which was also visible in representative images taken of the volunteers (figure 4). As both chromophores, haemoglobin, and melanin, can be stimulated by oxidative stress and inflammation, the improvement of the skin tone can be attributed to the anti-inflammatory and antioxidant effects of the combination of ingredients.

Conclusion 

Using the right formulation, CBD can be delivered into the skin, where a functional endocannabinoid system exists, which provides the molecular basis for its efficacy in the skin. Indeed, several in vitro studies have shown the anti-inflammatory, antioxidant, soothing and wound healing capacity of CBD in different skin models. These effects of CBD can be enhanced by combined synergistic treatments.

Correctly formulated CBD can exert beneficial effects on the skin and is a promising ingredient for cosmetic applications. 

References:

1 Abu-Sawwa R., Scutt B., Park Y. Emerging use of epidiolex (cannabidiol) in epilepsy. The Journal of Pediatric Pharmacology and Therapeutics. 2020, 25(6): 485-499.

2 Corroon J., Philips J.A. A cross-sectional study of cannabidiol users. Cannabis and Cannabinoid Research. 2018, 3(1): 152-161.

3 Baswan S.M., et al. Therapeutic potential of cannabidiol (CBD) for skin health and disorders. Clinical, Cosmetic and Investigational Dermatology. 2020, 13:927-942. 

4 Kendall A.C., et al. Distribution of bioactive lipid mediators in human skin. Journal of Investigative Dermatology. 2015, 135:1510-1520.

 5 □Casares L., et al. Cannabidiol induces antioxidant pathway in keratinocytes by targeting BACH1. Redox Biology. 2020, 28: 101321.

6 Jastrzab A., Gegotek A., Skrzydlewska E. Cannabidiol regulates the expression of keratinocyte proteins involved in the inflammation process through transcriptional regulation. Cells. 2019, 8(8):827.

7 Liu C., Li H. Cannabidiol protects human skin keratinocytes from hydrogen-peroxide-induced oxidative stress via modulation of the capsase-1-IL-1b axis. Journal of Natural Products. 2021, 84(5):1563-1572.

8 Gegotek A., Atalay S. The differences in the proteome profile of cannabidiol-treated skin fibroblasts following UVA or UVB irradiation in 2D and 3D cell cultures. Cells. 2019, 8(9):995.

9 Bisogno T., et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. British Journal of Pharmacology. 2001, 134:845-852.

10 Oláh A., et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. The Journal of Clinical Investigation. 2014, 124(9):3713-3724.

11 Dobrosi N., et al. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. The FASEB Journal, 2008, 22:3685-3695.

12 Lipobelle Pino C

Dr Katharina Kappler,
Study Manager,
Mibelle ­Biochemistry,
Buchs,Switzerland,
www.mibellebiochemistry.com 

More about:

Advertisement

News Ingredients

Advertisement